Clinical Biochemistry Practice Questions

Q: Which of the following enzymes becomes deficient following an episode of severe infectious gastroenteritis?

Lactase. **Explanation:** The correct answer is **Lactase**. This question tests the concept of **Secondary Lactose Intolerance** following mucosal injury. **Why Lactase is the correct answer:** Lactase is a brush-border disaccharidase located at the **tips of the intestinal villi**. In cases of severe infectious gastroenteritis (viral, bacterial, or protozoal like Giardia), the inflammatory process leads to villous atrophy and sloughing of the enterocytes. Because lactase is located most superficially on the villi compared to other disaccharidases (like sucrase or maltase), it is the first enzyme to be lost and the last to recover during mucosal healing. This leads to a temporary inability to digest lactose, resulting in osmotic diarrhea, bloating, and flatulence after milk ingestion. **Why the other options are incorrect:** * **Amylase, Trypsin, and Lipase:** These are **pancreatic enzymes** secreted by the acinar cells of the pancreas into the duodenal lumen. Since infectious gastroenteritis primarily affects the intestinal mucosa and not the pancreatic parenchyma, the production and secretion of these enzymes remain largely unaffected. **High-Yield Clinical Pearls for NEET-PG:** * **Location:** Lactase is found on the apical surface of differentiated enterocytes (brush border). * **Diagnosis:** Secondary lactose intolerance is often diagnosed via a **Hydrogen Breath Test** (increased $H_2$ due to bacterial fermentation of undigested lactose) or finding a **low stool pH** (acidic) with the presence of **reducing substances**. * **Recovery:** It may take 2–4 weeks for the brush border to regenerate and lactase levels to return to normal post-infection. * **Congenital vs. Acquired:** While congenital lactase deficiency is rare, secondary (acquired) deficiency is a common post-sequela of Rotavirus infection in children.

Q: Enzyme levels in tissue injury are due to which of the following mechanisms?

Lysis of cells. ### Explanation **1. Why "Lysis of cells" is correct:** In a healthy state, most metabolic enzymes are intracellular, maintained within the cytoplasm or organelles by the semi-permeable cell membrane. When tissue injury occurs—whether due to hypoxia, toxins, or mechanical trauma—the integrity of the cell membrane is compromised. This leads to **cell lysis** or increased membrane permeability, allowing intracellular enzymes to leak into the interstitial fluid and subsequently into the bloodstream. Therefore, an elevation of these enzymes in the serum serves as a diagnostic marker for specific organ damage. **2. Why the other options are incorrect:** * **Enzyme secretion:** This is a physiological process (e.g., pancreatic exocrine secretion of digestive enzymes into the gut). While some secreted enzymes are found in blood, a sudden pathological rise in serum levels is typically due to leakage from damage, not an increase in the active secretion process. * **Absence of inhibitors in serum:** Serum actually contains many inhibitors (e.g., $\alpha_1$-antitrypsin) to neutralize proteases. However, the *rise* in enzyme levels post-injury is due to the increased "source" (the damaged cell), not a sudden disappearance of baseline inhibitors. **3. Clinical Pearls for NEET-PG:** * **Rate of Release:** Small, cytoplasmic enzymes (e.g., LDH, CK) appear in the blood faster than large or membrane-bound enzymes. * **Organ Specificity:** * **ALT (Alanine Transaminase):** More specific for liver injury than AST. * **CK-MB:** Marker for Myocardial Infarction (rises within 4–6 hours). * **Lipase:** More specific for Acute Pancreatitis than Amylase. * **Key Concept:** Serum enzyme activity depends on the rate of release from damaged cells versus the rate of clearance from the circulation.

Q: 5'-Nucleotidase activity is increased in which of the following conditions?

Cholestatic disorder. **Explanation:** **5'-Nucleotidase (5'-NT)** is an enzyme found in various tissues but is primarily used as a clinical marker for hepatobiliary diseases. It is localized to the canalicular and sinusoidal membranes of hepatocytes. **1. Why Cholestatic Disorder is Correct:** In **cholestatic disorders** (obstructive jaundice), bile salts exert a detergent effect on the hepatocyte membranes, causing the release and induction of 5'-Nucleotidase into the serum. Its clinical significance lies in its high specificity for the liver. While both Alkaline Phosphatase (ALP) and 5'-NT rise in cholestasis, 5'-NT remains normal in bone diseases, making it the "gold standard" to differentiate the source of an elevated ALP. **2. Why Incorrect Options are Wrong:** * **Bone Diseases:** ALP is elevated in bone disorders (e.g., Paget’s, rickets), but **5'-NT is not found in bone**. Therefore, 5'-NT levels remain normal in bone diseases. * **Prostate Cancer:** The classic marker for prostate cancer (specifically metastatic) is **Acid Phosphatase (ACP)** and Prostate-Specific Antigen (PSA), not 5'-NT. * **Chronic Renal Failure:** This condition is associated with markers like elevated BUN, Creatinine, and sometimes secondary hyperparathyroidism (affecting ALP), but it does not typically cause an increase in 5'-NT. **High-Yield Clinical Pearls for NEET-PG:** * **Gamma-Glutamyl Transferase (GGT):** Like 5'-NT, GGT is also used to confirm the hepatic origin of ALP. However, GGT is also induced by **alcohol** and drugs (Phenytoin), whereas 5'-NT is not. * **Mnemonic:** "5'-NT is **N**ot **T**hrown by bone." * **ALP + High 5'-NT** = Hepatobiliary origin. * **ALP + Normal 5'-NT** = Bone origin.

Q: Elevated levels of serum glutamic oxaloacetic transaminase is indicative of what condition?

Liver disease. **Explanation:** **Serum Glutamic Oxaloacetic Transaminase (SGOT)**, also known as **Aspartate Aminotransferase (AST)**, is a pyridoxal phosphate (PLP)-dependent enzyme found primarily in the liver, heart, skeletal muscle, and kidneys. Under normal physiological conditions, SGOT remains intracellular. However, when there is damage to the hepatocytes (liver cells), the cell membrane integrity is compromised, causing the enzyme to leak into the bloodstream. Therefore, elevated serum levels serve as a sensitive biochemical marker for **liver disease**, such as viral hepatitis, alcoholic cirrhosis, or toxic liver injury. **Analysis of Options:** * **Option A & B:** SGOT is an enzyme that catalyzes the reversible transfer of an amino group between aspartate and alpha-ketoglutarate to form **glutamic acid** and **oxaloacetic acid**. Its elevation in the serum indicates cellular damage/leakage, not a nutritional deficiency of its substrates or products. * **Option C (Correct):** As explained, elevated SGOT is a hallmark of hepatocellular injury. **High-Yield Clinical Pearls for NEET-PG:** * **AST vs. ALT:** While SGOT (AST) is found in multiple organs, **SGPT (ALT)** is more specific to the liver. * **De Ritis Ratio (AST/ALT):** * A ratio **> 2:1** is highly suggestive of **Alcoholic Liver Disease**. * A ratio **< 1** is typically seen in **Viral Hepatitis**. * **Myocardial Infarction (MI):** Historically, SGOT was used as a cardiac marker as it rises 6–8 hours after an MI, though it has been replaced by more specific markers like Troponin T/I. * **Co-enzyme:** Remember that all transaminases require **Vitamin B6 (Pyridoxine)** as a cofactor.

Q: Which of the following is a marker for biliary tract obstruction?

Alkaline phosphatase. **Explanation:** **Alkaline Phosphatase (ALP)** is the correct answer because it is a classic marker of **cholestasis** (biliary tract obstruction). ALP is an enzyme found on the canalicular membranes of hepatocytes and the epithelial cells lining the bile ducts. When bile flow is obstructed (due to gallstones, tumors, or strictures), the increased pressure and the detergent action of accumulated bile salts cause the induction and release of ALP into the bloodstream. **Analysis of Incorrect Options:** * **Alanine Transaminase (ALT) & Aspartate Transaminase (AST):** These are markers of **hepatocellular injury**. While they may be mildly elevated in biliary obstruction, their primary diagnostic value lies in detecting damage to the liver parenchyma (e.g., viral hepatitis or drug-induced liver injury). ALT is more specific to the liver than AST. * **Creatinine Kinase (CK):** This is a marker for **muscle damage** (skeletal or cardiac). It has no diagnostic relevance to the biliary system or liver function. **High-Yield Clinical Pearls for NEET-PG:** * **Gamma-Glutamyl Transferase (GGT):** This is the most sensitive marker for biliary obstruction and is used to confirm that an elevated ALP is of hepatic origin (rather than bone). * **Pattern Recognition:** A disproportionate rise in ALP compared to ALT/AST suggests an **obstructive (cholestatic) pattern**, whereas a disproportionate rise in ALT/AST suggests a **hepatocellular pattern**. * **Other ALP Sources:** Remember that ALP is also found in **bone** (osteoblastic activity), the **placenta** (Regan isoenzyme), and the **intestine**. Always check GGT to differentiate.

Q: Which of the following is not a test for diabetes mellitus?

Oral Glucose tolerance test. **Explanation:** The question asks to identify which test is **not** used for the diagnosis of Diabetes Mellitus. **Correct Answer: C. D-Xylose test** *(Note: The provided prompt indicates Option D as correct, but medically, the D-Xylose test is the one NOT used for diabetes. The Oral Glucose Tolerance Test (OGTT) is a standard diagnostic tool for diabetes.)* The **D-Xylose test** is a diagnostic tool used to evaluate the **absorptive capacity of the proximal small intestine**. It is primarily used to differentiate between malabsorption caused by intestinal mucosal disease (e.g., Celiac disease) and malabsorption due to pancreatic insufficiency. Since D-Xylose is a pentose sugar that does not require pancreatic enzymes for digestion, its low excretion in urine indicates intestinal mucosal damage, not a disorder of glucose metabolism. **Analysis of other options:** * **Fasting Blood Glucose (FBG):** A primary diagnostic test. A value $\geq 126$ mg/dL on two separate occasions is diagnostic for Diabetes. * **Random Blood Glucose (RBG):** Used in symptomatic patients (polyuria, polydipsia). A value $\geq 200$ mg/dL with symptoms confirms Diabetes. * **Oral Glucose Tolerance Test (OGTT):** The "gold standard" for diagnosing Gestational Diabetes and used when FBG is inconclusive. A 2-hour post-load value $\geq 200$ mg/dL is diagnostic. **High-Yield Clinical Pearls for NEET-PG:** 1. **HbA1c:** Reflects average blood glucose over the previous 8–12 weeks. A level $\geq 6.5\%$ is diagnostic for Diabetes. 2. **Renal Threshold for Glucose:** Approximately **180 mg/dL**. Glucosuria occurs when blood glucose exceeds this level. 3. **Microalbuminuria:** The earliest clinical sign of diabetic nephropathy (30–300 mg/day). 4. **D-Xylose vs. Schilling Test:** Remember, D-Xylose is for **malabsorption**, while the Schilling test (now largely historical) was for **Vitamin B12 absorption**.

Q: The Schilling test is abnormal in which of the following conditions?

Intrinsic factor deficiency. **Explanation:** The **Schilling test** is a classic diagnostic tool used to determine the cause of Vitamin B12 (cobalamin) malabsorption. **Why Option A is Correct:** Vitamin B12 absorption requires **Intrinsic Factor (IF)**, a glycoprotein secreted by the gastric parietal cells. In the duodenum, B12 binds to IF to form a complex that is later absorbed in the terminal ileum. In conditions like **Pernicious Anemia** (autoimmune destruction of parietal cells) or gastrectomy, IF deficiency leads to B12 malabsorption. The Schilling test involves administering radiolabeled B12; if the absorption is corrected by adding exogenous IF in the second stage of the test, it confirms IF deficiency as the cause. **Why the Other Options are Incorrect:** * **B & C (Amylase and Lipase deficiency):** These are pancreatic **exocrine** enzymes involved in the digestion of carbohydrates and fats, respectively. While pancreatic proteases (like trypsin) are needed to degrade R-binders to allow B12 to bind to IF, amylase and lipase have no role in B12 metabolism. * **D (Pancreatic endocrine insufficiency):** This refers to a lack of hormones like insulin or glucagon (e.g., in Diabetes Mellitus). It does not affect the digestive or absorptive processes required for Vitamin B12. Note: *Exocrine* pancreatic insufficiency can cause an abnormal Schilling test, but *endocrine* insufficiency does not. **High-Yield Clinical Pearls for NEET-PG:** * **Stages of Schilling Test:** * Stage I: Oral B12 alone (checks general absorption). * Stage II: Oral B12 + Intrinsic Factor (corrects Pernicious Anemia). * Stage III: Oral B12 + Antibiotics (corrects SIBO/Blind Loop Syndrome). * Stage IV: Oral B12 + Pancreatic enzymes (corrects Chronic Pancreatitis). * **Site of B12 absorption:** Terminal Ileum. * **Common presentation:** Megaloblastic anemia with neurological symptoms (Subacute Combined Degeneration of the Spinal Cord).

Q: Vanillylmandelic acid (VMA) is elevated in which of the following conditions?

Pheochromocytoma. **Explanation:** **Pheochromocytoma** is a catecholamine-secreting tumor arising from the chromaffin cells of the adrenal medulla. These tumors overproduce epinephrine and norepinephrine. In the body, catecholamines are metabolized by two key enzymes: **COMT** (Catechol-O-methyltransferase) and **MAO** (Monoamine oxidase). The final end-product of this metabolic pathway is **Vanillylmandelic Acid (VMA)**. Consequently, a 24-hour urinary VMA test is a classic diagnostic marker for Pheochromocytoma, reflecting the excessive production and degradation of catecholamines. **Analysis of Incorrect Options:** * **Conn’s Syndrome:** This is primary hyperaldosteronism caused by an aldosterone-secreting adenoma. It presents with hypertension and hypokalemia, but catecholamine levels and VMA remain normal. * **Carcinoid Syndrome:** This involves tumors (usually in the midgut) that secrete excessive **serotonin**. The diagnostic marker for this condition is elevated urinary **5-HIAA** (5-Hydroxyindoleacetic acid), not VMA. * **Tuberous Sclerosis:** This is a neurocutaneous autosomal dominant disorder characterized by hamartomas in various organs (e.g., facial angiofibromas, renal angiomyolipomas). It is not associated with catecholamine overproduction. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** While VMA is a traditional marker, **urinary or plasma metanephrines** are now considered more sensitive and are the preferred initial screening test for Pheochromocytoma. * **Rule of 10s:** Pheochromocytoma is famously known as the "10% tumor" (10% bilateral, 10% malignant, 10% extra-adrenal, 10% pediatric, 10% familial). * **Associated Syndromes:** Always screen for Pheochromocytoma in patients with **MEN 2A and 2B**, Von Hippel-Lindau (VHL) disease, and Neurofibromatosis type 1 (NF1).

Q: Which of the following does NOT cause an increase in serum amylase?

Cardiac failure. **Explanation:** Serum amylase is a key biomarker in clinical biochemistry, primarily produced by the pancreas and salivary glands. Understanding its elevation patterns is crucial for differential diagnosis. **1. Why Cardiac Failure is the Correct Answer:** Cardiac failure does not typically cause an elevation in serum amylase. It primarily leads to systemic venous congestion, affecting the liver (causing elevated transaminases) or the lungs (pulmonary edema), but it has no direct pathophysiological mechanism that triggers the release of amylase from pancreatic or extrapancreatic tissues. **2. Analysis of Incorrect Options:** * **Pancreatitis (Option A):** This is the most common cause. Inflammation or necrosis of pancreatic acinar cells leads to the leakage of amylase into the bloodstream, often reaching levels >3 times the upper limit of normal. * **Carcinoma Lung (Option B):** Certain non-pancreatic tumors, particularly **small cell lung cancer** or ovarian tumors, can produce amylase ectopically (ectopic hyperamylasemia). * **Renal Failure (Option C):** Amylase is a small molecule cleared by the kidneys. In renal failure, the glomerular filtration rate (GFR) decreases, leading to reduced clearance and a subsequent rise in serum amylase levels (usually 2–3 times normal). **Clinical Pearls for NEET-PG:** * **Macroamylasemia:** A condition where amylase binds to immunoglobulins (IgA/IgG), forming a complex too large to be filtered by the kidney, leading to high serum amylase but **low urinary amylase**. * **P-isoamylase vs. S-isoamylase:** P-type is specific to the pancreas; S-type is found in salivary glands, lungs, and fallopian tubes. * **Lipase:** More specific than amylase for acute pancreatitis and remains elevated longer (7–14 days). * **Other causes of high amylase:** Mumps (parotitis), perforated peptic ulcer, and ectopic pregnancy.

Q: Which of the following is true regarding unconjugated bilirubin?

Bound with serum albumin. **Explanation:** Bilirubin is the end product of heme catabolism. Understanding the physical properties of its two forms—unconjugated and conjugated—is high-yield for NEET-PG. **Why Option D is correct:** Unconjugated bilirubin (UCB) is a **hydrophobic (lipophilic)** molecule. Because it cannot dissolve in the aqueous environment of the plasma, it must be transported to the liver bound to **serum albumin**. This binding is non-covalent but strong, preventing the UCB from diffusing into tissues under normal physiological conditions. **Why other options are incorrect:** * **Options A & B:** Unconjugated bilirubin is highly **lipid-soluble** and has very low water solubility. Its structure involves internal hydrogen bonding that hides its polar groups, making it hydrophobic. It is conjugated with glucuronic acid in the liver (by UDP-glucuronosyltransferase) specifically to make it water-soluble. * **Option C:** Because UCB is bound to albumin, the complex is too large to pass through the glomerular basement membrane. Therefore, **UCB is never excreted in urine**, even in cases of severe unconjugated hyperbilirubinemia (e.g., Crigler-Najjar syndrome). Only conjugated bilirubin, which is water-soluble and not tightly bound to albumin, can be excreted by the kidneys ("choluric jaundice"). **High-Yield Clinical Pearls for NEET-PG:** 1. **Kernicterus:** Because UCB is lipid-soluble, it can cross the blood-brain barrier if levels exceed the binding capacity of albumin, leading to neurotoxicity in neonates. 2. **Van den Bergh Reaction:** UCB gives an **indirect** positive reaction (requires alcohol to break hydrogen bonds), while conjugated bilirubin gives a **direct** reaction. 3. **Acholuric Jaundice:** Conditions like hemolytic anemia show elevated UCB; since UCB cannot enter urine, these patients have jaundice without bilirubinuria.

Question 1

Which of the following enzymes becomes deficient following an episode of severe infectious gastroenteritis?

Accepted Answer

Lactase

Answer

Amylase

Answer

Trypsin

Answer

Lipase

Question 2

Enzyme levels in tissue injury are due to which of the following mechanisms?

Accepted Answer

Lysis of cells

Answer

Enzyme secretion

Answer

Absence of inhibitors in serum

Answer

All of the above

Question 3

5'-Nucleotidase activity is increased in which of the following conditions?

Accepted Answer

Cholestatic disorder

Answer

Bone diseases

Answer

Prostate cancer

Answer

Chronic renal failure

Question 4

Elevated levels of serum glutamic oxaloacetic transaminase is indicative of what condition?

Accepted Answer

Liver disease

Answer

Deficiency of glutamic acid

Answer

Deficiency of oxaloacetic acid

Answer

All of the above

Question 5

Which of the following is a marker for biliary tract obstruction?

Accepted Answer

Alkaline phosphatase

Answer

Aspartate transaminase

Answer

Alanine transaminase

Answer

Creatinine kinase

Question 6

Which of the following is not a test for diabetes mellitus?

Accepted Answer

Oral Glucose tolerance test

Answer

Fasting blood glucose

Answer

Random blood glucose

Answer

D-Xylose test

Question 7

The Schilling test is abnormal in which of the following conditions?

Accepted Answer

Intrinsic factor deficiency

Answer

Amylase deficiency

Answer

Lipase deficiency

Answer

Pancreatic endocrine insufficiency

Question 8

Vanillylmandelic acid (VMA) is elevated in which of the following conditions?

Accepted Answer

Pheochromocytoma

Answer

Conn's syndrome

Answer

Carcinoid syndrome

Answer

Tuberous sclerosis

Question 9

Which of the following does NOT cause an increase in serum amylase?

Accepted Answer

Cardiac failure

Answer

Pancreatitis

Answer

Carcinoma lung

Answer

Renal failure

Question 10

Which of the following is true regarding unconjugated bilirubin?

Accepted Answer

Bound with serum albumin

Answer

Not lipid soluble

Answer

More water soluble

Answer

Excreted by kidney easily

Clinical Biochemistry — MCQs

Clinical Biochemistry — MCQs

On this page

Practice by Chapter

Want unlimited practice?